EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression

Julian Maciaszek, Tomasz Pawłowski iD, Tomasz Hadryś, Marta Machowska, Anna Wiela-Hojeńska iD, Błażej Misiak

International Journal of Molecular Sciences · 30.08.2023 · 24 (17) · 13459

DOI: 10.3390/ijms241713459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.08.2023. Verfasst von Julian Maciaszek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland. Hauptthemen laut MEDLINE: Major Depressive Disorder, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by the budget for science in the years 2017-2020, as a research project under the "Diamentowy Grant" program: "CYP 2D6 and CYP 1A2 pol…, “Diamentowy Grant” program: “CYP 2D6 and CYP 1A2 polymorphisms and the efficacy and tolerability of duloxetine in the treatment of depression”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is a global mental health concern, and personalized treatment approaches are needed to optimize its management. This study aimed to investigate the influence of the CYP2D6 and CYP1A2 gene polymorphisms on the efficacy of duloxetine in reducing depressive and anxiety symptoms. A sample of 100 outpatients with major depression, who initiated monotherapy with duloxetine, were followed up. Polymorphisms in the CYP2D6 and CYP1A2 genes were assessed. The severity of depressive and anxiety symptoms was recorded using standardized scales. Adverse drug reactions (ADRs) were analyzed. Statistical analyses, including linear regression, were conducted to examine the relationships between genetic polymorphisms, clinical variables, and treatment outcomes. Patients with higher values of the duloxetine metabolic index (DMI) for CYP2D6, indicating a faster metabolism, achieved a greater reduction in anxiety symptoms. The occurrence of ADRs was associated with a lower reduction in anxiety symptoms. However, no significant associations were found between studied gene polymorphisms and reduction in depressive symptoms. No significant effects of the DMI for CYP1A2 were found. Patients with a slower metabolism may experience less benefit from duloxetine therapy in terms of anxiety symptom reduction. Personalizing treatment based on the CYP2D6 and CYP1A2 gene polymorphisms can enhance the effectiveness of antidepressant therapy and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderDrug-Related Side Effects and Adverse ReactionsHumansCytochrome P-450 CYP2D6Cytochrome P-450 CYP1A2Duloxetine HydrochlorideDepressionPolymorphism, Genetic

Stichwörter der Autor:innen

CYP1A2CYP2D6anxiety symptomsduloxetineefficacymajor depressionpolymorphismspredictiontolerability

Substanzen

Cytochrome P-450 CYP2D6Cytochrome P-450 CYP1A2Duloxetine HydrochlorideCYP1A2 protein, human

Autor:innen und Institutionen

  • Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland.
  • Department of Clinical Pharmacology, Wroclaw Medical University, 50-367 Wroclaw, Poland.

ORCID-Profile: Tomasz Pawłowski, Anna Wiela-Hojeńska

Förderung

  • This research was funded by the budget for science in the years 2017-2020, as a research project under the "Diamentowy Grant" program: "CYP 2D6 and CYP 1A2 pol…
  • “Diamentowy Grant” program: “CYP 2D6 and CYP 1A2 polymorphisms and the efficacy and tolerability of duloxetine in the treatment of depression”

Zitieren

APA

Maciaszek, J., Pawłowski, T., Hadryś, T., Machowska, M., Wiela-Hojeńska, A., & Misiak, B. (2023). The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression. International Journal of Molecular Sciences, 24(17), 13459. https://doi.org/10.3390/ijms241713459

Vancouver

Maciaszek J, Pawłowski T, Hadryś T, Machowska M, Wiela-Hojeńska A, Misiak B. The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression. International Journal of Molecular Sciences. 2023;24(17):13459. doi:10.3390/ijms241713459

BibTeX
@article{Maciaszek2023,
  author = {Maciaszek, Julian and Pawłowski, Tomasz and Hadryś, Tomasz and Machowska, Marta and Wiela-Hojeńska, Anna and Misiak, Błażej},
  title = {The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {17},
  pages = {13459},
  doi = {10.3390/ijms241713459}
}
Kostenlos starten →